Niagen Bioscience (NAGE) Depreciation and amortization

annual D&A:

$1.48M-$221.00K(-12.96%)
December 1, 2024

Summary

  • As of today (June 17, 2025), NAGE annual depreciation & amortization is $1.48 million, with the most recent change of -$221.00 thousand (-12.96%) on December 1, 2024.
  • During the last 3 years, NAGE annual D&A has fallen by -$142.00 thousand (-8.73%).
  • NAGE annual D&A is now -21.23% below its all-time high of $1.88 million, reached on December 1, 2022.

Performance

NAGE Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEincome statement metrics

quarterly D&A:

$368.00K+$10.00K(+2.79%)
March 1, 2025

Summary

  • As of today (June 17, 2025), NAGE quarterly depreciation & amortization is $368.00 thousand, with the most recent change of +$10.00 thousand (+2.79%) on March 1, 2025.
  • Over the past year, NAGE quarterly D&A has dropped by -$22.00 thousand (-5.64%).
  • NAGE quarterly D&A is now -32.97% below its all-time high of $549.00 thousand, reached on March 1, 2022.

Performance

NAGE quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEincome statement metrics

TTM D&A:

$1.46M-$22.00K(-1.48%)
March 1, 2025

Summary

  • As of today (June 17, 2025), NAGE TTM depreciation & amortization is $1.46 million, with the most recent change of -$22.00 thousand (-1.48%) on March 1, 2025.
  • Over the past year, NAGE TTM D&A has dropped by -$193.00 thousand (-11.66%).
  • NAGE TTM D&A is now -22.40% below its all-time high of $1.88 million, reached on December 1, 2022.

Performance

NAGE TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNAGEincome statement metrics

NAGE Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-13.0%-5.6%-11.7%
3 y3 years-8.7%-33.0%-17.3%
5 y5 years-2.6%0.0%-2.5%

NAGE Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-21.2%at low-19.1%+2.8%-22.4%at low
5 y5-year-21.2%at low-33.0%+2.8%-22.4%at low
alltimeall time-21.2%+474.5%-33.0%+528.0%-22.4%+1378.3%

NAGE Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$368.00K(+2.8%)
$1.46M(-1.5%)
Dec 2024
$1.48M(-13.0%)
$358.00K(-2.2%)
$1.48M(-1.0%)
Sep 2024
-
$366.00K(-1.1%)
$1.50M(-5.2%)
Jun 2024
-
$370.00K(-5.1%)
$1.58M(-4.5%)
Mar 2024
-
$390.00K(+4.6%)
$1.66M(-2.9%)
Dec 2023
$1.71M(-9.5%)
$373.00K(-16.7%)
$1.71M(-4.6%)
Sep 2023
-
$448.00K(+0.9%)
$1.79M(-0.1%)
Jun 2023
-
$444.00K(+0.9%)
$1.79M(+0.7%)
Mar 2023
-
$440.00K(-3.3%)
$1.77M(-5.8%)
Dec 2022
$1.88M(+15.9%)
$455.00K(+1.3%)
$1.88M(+3.7%)
Sep 2022
-
$449.00K(+4.2%)
$1.82M(+1.8%)
Jun 2022
-
$431.00K(-21.5%)
$1.78M(+0.9%)
Mar 2022
-
$549.00K(+41.5%)
$1.77M(+8.7%)
Dec 2021
$1.63M(+7.5%)
$388.00K(-6.7%)
$1.63M(-0.4%)
Sep 2021
-
$416.00K(+0.2%)
$1.63M(+2.4%)
Jun 2021
-
$415.00K(+2.0%)
$1.59M(+2.7%)
Mar 2021
-
$407.00K(+3.0%)
$1.55M(+2.6%)
Dec 2020
$1.51M(-0.7%)
$395.00K(+4.8%)
$1.51M(+2.6%)
Sep 2020
-
$377.00K(+1.1%)
$1.48M(-1.7%)
Jun 2020
-
$373.00K(+1.4%)
$1.50M(-1.3%)
Mar 2020
-
$368.00K(+3.1%)
$1.52M(-0.3%)
Dec 2019
$1.52M(+80.9%)
$357.00K(-11.2%)
$1.52M(+9.0%)
Sep 2019
-
$402.00K(+2.6%)
$1.40M(+14.2%)
Jun 2019
-
$392.00K(+5.4%)
$1.22M(+18.2%)
Mar 2019
-
$372.00K(+61.0%)
$1.03M(+22.9%)
Dec 2018
$842.00K(+17.6%)
$231.00K(+1.3%)
$842.00K(+7.5%)
Sep 2018
-
$228.00K(+11.8%)
$783.00K(+5.1%)
Jun 2018
-
$204.00K(+14.0%)
$745.00K(+0.4%)
Mar 2018
-
$179.00K(+4.1%)
$742.00K(+3.6%)
Dec 2017
$716.00K(+70.6%)
$172.00K(-9.5%)
$716.00K(+7.5%)
Sep 2017
-
$190.00K(-5.5%)
$666.00K(+15.7%)
Jun 2017
-
$201.00K(+31.4%)
$575.70K(+20.3%)
Mar 2017
-
$153.00K(+25.4%)
$478.70K(+14.1%)
DateAnnualQuarterlyTTM
Dec 2016
$419.60K(+26.9%)
$122.00K(+22.4%)
$419.50K(+8.7%)
Sep 2016
-
$99.70K(-4.1%)
$386.10K(+4.2%)
Jun 2016
-
$104.00K(+10.9%)
$370.60K(+6.7%)
Mar 2016
-
$93.80K(+5.9%)
$347.40K(+5.1%)
Dec 2015
$330.60K(+28.0%)
$88.60K(+5.2%)
$330.60K(+5.4%)
Sep 2015
-
$84.20K(+4.2%)
$313.80K(+6.9%)
Jun 2015
-
$80.80K(+4.9%)
$293.60K(+6.1%)
Mar 2015
-
$77.00K(+7.2%)
$276.80K(+7.1%)
Dec 2014
$258.30K(-4.2%)
$71.80K(+12.2%)
$258.40K(+2.6%)
Sep 2014
-
$64.00K(0.0%)
$251.80K(+1.8%)
Jun 2014
-
$64.00K(+9.2%)
$247.30K(+1.3%)
Mar 2014
-
$58.60K(-10.1%)
$244.10K(-9.5%)
Dec 2013
$269.70K(-21.6%)
$65.20K(+9.6%)
$269.60K(-7.0%)
Sep 2013
-
$59.50K(-2.1%)
$289.90K(-8.1%)
Jun 2013
-
$60.80K(-27.7%)
$315.40K(-7.0%)
Mar 2013
-
$84.10K(-1.6%)
$339.30K(-1.4%)
Dec 2012
$344.00K(-13.8%)
$85.50K(+0.6%)
$344.00K(-3.0%)
Sep 2012
-
$85.00K(+0.4%)
$354.50K(-4.1%)
Jun 2012
-
$84.70K(-4.6%)
$369.60K(-4.6%)
Mar 2012
-
$88.80K(-7.5%)
$387.30K(-2.9%)
Dec 2011
$398.90K(+3.0%)
$96.00K(-4.1%)
$398.80K(-0.9%)
Sep 2011
-
$100.10K(-2.2%)
$402.40K(+0.2%)
Jun 2011
-
$102.40K(+2.1%)
$401.70K(+1.6%)
Mar 2011
-
$100.30K(+0.7%)
$395.20K(+2.0%)
Dec 2010
$387.40K(-1.8%)
$99.60K(+0.2%)
$387.40K(+0.1%)
Sep 2010
-
$99.40K(+3.6%)
$387.00K(+0.6%)
Jun 2010
-
$95.90K(+3.7%)
$384.80K(-0.9%)
Mar 2010
-
$92.50K(-6.8%)
$388.20K(-1.6%)
Dec 2009
$394.50K(+4.8%)
$99.20K(+2.1%)
$394.60K(+33.6%)
Sep 2009
-
$97.20K(-2.1%)
$295.40K(+49.0%)
Jun 2009
-
$99.30K(+0.4%)
$198.20K(+100.4%)
Mar 2009
-
$98.90K
$98.90K
Dec 2008
$376.30K
-
-

FAQ

  • What is Niagen Bioscience annual depreciation & amortization?
  • What is the all time high annual D&A for Niagen Bioscience?
  • What is Niagen Bioscience annual D&A year-on-year change?
  • What is Niagen Bioscience quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Niagen Bioscience?
  • What is Niagen Bioscience quarterly D&A year-on-year change?
  • What is Niagen Bioscience TTM depreciation & amortization?
  • What is the all time high TTM D&A for Niagen Bioscience?
  • What is Niagen Bioscience TTM D&A year-on-year change?

What is Niagen Bioscience annual depreciation & amortization?

The current annual D&A of NAGE is $1.48M

What is the all time high annual D&A for Niagen Bioscience?

Niagen Bioscience all-time high annual depreciation & amortization is $1.88M

What is Niagen Bioscience annual D&A year-on-year change?

Over the past year, NAGE annual depreciation & amortization has changed by -$221.00K (-12.96%)

What is Niagen Bioscience quarterly depreciation & amortization?

The current quarterly D&A of NAGE is $368.00K

What is the all time high quarterly D&A for Niagen Bioscience?

Niagen Bioscience all-time high quarterly depreciation & amortization is $549.00K

What is Niagen Bioscience quarterly D&A year-on-year change?

Over the past year, NAGE quarterly depreciation & amortization has changed by -$22.00K (-5.64%)

What is Niagen Bioscience TTM depreciation & amortization?

The current TTM D&A of NAGE is $1.46M

What is the all time high TTM D&A for Niagen Bioscience?

Niagen Bioscience all-time high TTM depreciation & amortization is $1.88M

What is Niagen Bioscience TTM D&A year-on-year change?

Over the past year, NAGE TTM depreciation & amortization has changed by -$193.00K (-11.66%)
On this page